Clinique Ovo
Montreal, Quebec, H4P 2S4, Canada
NCT Number: NCT06053827
In frozen embryo transfer substituted cycles, patients are treated with progesterone and estrogen in an attempt to mimic the natural cycle and a transfer is planned whenever the endometrium is ready. In contrast, in frozen embryo transfer natural cycle patients are not taking any hormones, only triggered with hCG (human chorionic gonadotropin) when a dominant follicle is ready or they wait for the disappearance of the dominant follicle to plan the transfer date. Some doctors and centres shift towards using the substituted protocol in an attempt to make scheduling easier with less frequent ultrasounds.
This study will aim to compare clinical and biochemical pregnancy rates in patients who underwent frozen embryo transfers in natural cycles vs substituted cycles at the centre.
Looking for future studies?
Notify MeUp to 40 year
Female
Observational
Montreal, Quebec, H4P 2S4, Canada
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A frozen embryo transfer involves thawing a fertilized embryo and transferring it in the uterus in order to obtain a pregnancy
Time frame: 6 to 8 weeks after Frozen Embryo Transfer
clinical pregnancy is the presence of fetal heartbeat at the viability ultrasound
Clinique Ovo
Industry
Embryo Transfer in Natural vs Substituted Cycle and the Scheduling Pattern of IVF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07464275
Fertility Disorders, Genital Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT05271981
Connective Tissue Diseases, Fertility Disorders
Paris, France
View Trial DetailsNCT03085433
Embryo Quality, Fertility Disorders
San Francisco, California, United States
View Trial DetailsNCT06128395
Fertility Disorders
Montreal, Quebec, Canada
View Trial Details